Bellicum Pharmaceuticals, Inc. BPX-501 Studies Placed on Hold
Bellicum’s Share Price Drops Sharply During Intraday Trading on January 31, 2018 Post-market, on January 30, 2018, Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) announced (“Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States”) that Bellicum Pharmaceuticals . .... Read More →
Alleged AriseBank Initial Coin Offering Scam Stopped
SEC Stops AriseBank’s Allegedly Fraudulent Initial Coin Offering Targeting Retail Investors to Fund the World’s First “Decentralized Bank.” AriseBank Used Social Media and Celebrity Endorsements to Raise $600 Million of Its $1 Billion Goal in Two Months Unregistered Investments in... Read More →